These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19109173)

  • 1. Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes.
    Perosa F; Favoino E; Vicenti C; Guarnera A; Racanelli V; De Pinto V; Dammacco F
    J Immunol; 2009 Jan; 182(1):416-23. PubMed ID: 19109173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: implication for peptide-based active immunotherapy.
    Perosa F; Favoino E; Vicenti C; Merchionne F; Dammacco F
    J Immunol; 2007 Dec; 179(11):7967-74. PubMed ID: 18025245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor.
    Perosa F; Favoino E; Caragnano MA; Dammacco F
    Blood; 2006 Feb; 107(3):1070-7. PubMed ID: 16223774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading.
    Favoino E; Prete M; Catacchio G; Conteduca G; Perosa F
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.
    Teeling JL; Mackus WJ; Wiegman LJ; van den Brakel JH; Beers SA; French RR; van Meerten T; Ebeling S; Vink T; Slootstra JW; Parren PW; Glennie MJ; van de Winkel JG
    J Immunol; 2006 Jul; 177(1):362-71. PubMed ID: 16785532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epitope recognized by rituximab.
    Binder M; Otto F; Mertelsmann R; Veelken H; Trepel M
    Blood; 2006 Sep; 108(6):1975-8. PubMed ID: 16705086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases.
    Perosa F; Favoino E; Caragnano MA; Dammacco F
    Ann N Y Acad Sci; 2005 Jun; 1051():672-83. PubMed ID: 16127008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies.
    Li M; Yan Z; Han W; Zhang Y
    Cell Immunol; 2006 Feb; 239(2):136-43. PubMed ID: 16814270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties.
    Klein C; Lammens A; Schäfer W; Georges G; Schwaiger M; Mössner E; Hopfner KP; Umaña P; Niederfellner G
    MAbs; 2013; 5(1):22-33. PubMed ID: 23211638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for recognition of CD20 by therapeutic antibody Rituximab.
    Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Huo S; Guo Y; Ding J
    J Biol Chem; 2007 May; 282(20):15073-80. PubMed ID: 17395584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure.
    Polyak MJ; Deans JP
    Blood; 2002 May; 99(9):3256-62. PubMed ID: 11964291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies.
    Witsch EJ; Mahlknecht G; Wakim J; Sertchook R; Bublil E; Yarden Y; Sela M
    Int Immunol; 2011 Jun; 23(6):391-403. PubMed ID: 21602175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.
    van Meerten T; Rozemuller H; Hol S; Moerer P; Zwart M; Hagenbeek A; Mackus WJ; Parren PW; van de Winkel JG; Ebeling SB; Martens AC
    Haematologica; 2010 Dec; 95(12):2063-71. PubMed ID: 20851867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of anti-CD20 humanized antibody hu8E4 by site-directed mutation based on epitope analysis.
    Chen Y; Chen L; Lu Q; Meng Y; Wang C; Wang L; Wang H; Yu X; Zhang Y; Zhao L; Li B; Guo Y
    Biochem Biophys Res Commun; 2015 Apr; 459(4):617-22. PubMed ID: 25749344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide.
    Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Hou S; Guo Y; Ding J
    Mol Immunol; 2008 May; 45(10):2861-8. PubMed ID: 18346788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide mimotopes of pneumococcal capsular polysaccharide of 6B serotype: a peptide mimotope can bind to two unrelated antibodies.
    Shin JS; Yu J; Lin J; Zhong L; Bren KL; Nahm MH
    J Immunol; 2002 Jun; 168(12):6273-8. PubMed ID: 12055241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death.
    Wittman VP; Woodburn D; Nguyen T; Neethling FA; Wright S; Weidanz JA
    J Immunol; 2006 Sep; 177(6):4187-95. PubMed ID: 16951384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide.
    Valadon P; Nussbaum G; Oh J; Scharff MD
    J Immunol; 1998 Aug; 161(4):1829-36. PubMed ID: 9712050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
    Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
    Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel humanized anti-CD20 antibody with potent anti-tumor activity against non-Hodgkin's lymphoma.
    Zhang H; Song L; Ye H; Hu L; Liang W; Liu D
    Cell Physiol Biochem; 2013; 32(3):645-54. PubMed ID: 24022075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.